Financhill
Back

Maze Therapeutics, Inc. Stock Predictions

Maze Therapeutics, Inc. Stock Forecast

  • Is Maze Therapeutics, Inc. Stock Undervalued?
    The current Maze Therapeutics, Inc. [MAZE] share price is $45.04. The Score for MAZE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • MAZE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Maze Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Maze Therapeutics, Inc. Stock Rating

Data Unavailable

Maze Therapeutics, Inc. Stock Price History

Is MAZE stock going to rise?

  • The current trend is moderately bearish and MAZE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
mazetx.com

52-Week Data

52-Week High:
49.25
52-Week Low:
6.71

Prediction Charts

Market Cap:
2.2B
Price in USD:
45.04
Volume:
291.2K
Beta:
4.83

Technical Analysis

SMA50:
42.71
SMA100:
37.23
SMA200:
25.83
52-Wk Change:
258.6%

Stock Predictions

  • Is Maze Therapeutics, Inc. stock public?
    Yes, Maze Therapeutics, Inc. is a publicly traded company.
  • What is the Maze Therapeutics, Inc. stock quote today?
    The Maze Therapeutics, Inc. stock price is 45.04 USD today.
  • How to buy Maze Therapeutics, Inc. stock online?
    You can buy Maze Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-30 44.10 43.58 45.66 43.39
Feb-2 43.56 46.53 47.32 42.94
Feb-3 46.82 47.97 48.75 45.74
Feb-4 48.22 48.14 48.94 46.58
Feb-5 46.70 43.95 49.25 42.17
Feb-6 44.29 45.03 46.18 42.79
Feb-9 45.09 47.71 47.90 43.89
Feb-10 47.63 48.37 48.52 45.22
Feb-11 48.37 47.22 48.44 44.30
Feb-12 47.30 47.04 47.85 45.51
Feb-13 47.00 46.01 48.76 45.89
Feb-17 46.01 46.97 47.86 44.54
Feb-18 47.80 45.08 48.03 44.99
Feb-19 45.01 45.04 46.57 42.56

Maze Therapeutics, Inc. Earnings

Data Unavailable

Maze Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.24 per share.

* Maze Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.